Bal Pharma Limited (BALPHARMA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bal Pharma Limited (BALPHARMA) has a cash flow conversion efficiency ratio of 0.129x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs101.16 Million ≈ $1.09 Million USD) by net assets (Rs783.30 Million ≈ $8.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Bal Pharma Limited (BALPHARMA) total market value for the company's overall valuation and market capitalisation.
Bal Pharma Limited - Cash Flow Conversion Efficiency Trend (2006–2026)
This chart illustrates how Bal Pharma Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Bal Pharma Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bal Pharma Limited ranked by their cash flow conversion efficiency. Explore Bal Pharma Limited (BALPHARMA) cash flow quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Netel Holding AB
ST:NETEL
|
0.093x |
|
Moorim SP Co. Ltd
KQ:001810
|
-0.006x |
|
Austin Gold Corp
NYSE MKT:AUST
|
-0.013x |
|
Pixelplus. Co. Ltd
KQ:087600
|
-0.002x |
|
Urteste SA
WAR:URT
|
-0.185x |
|
Manganese X Energy Corp
V:MN
|
-0.417x |
|
bioAffinity Technologies, Inc.
NASDAQ:BIAF
|
-0.352x |
|
Sirius Real Estate Limited
LSE:SRE
|
0.030x |
Annual Cash Flow Conversion Efficiency for Bal Pharma Limited (2006–2026)
The table below shows the annual cash flow conversion efficiency of Bal Pharma Limited from 2006 to 2026. View Bal Pharma Limited (BALPHARMA) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs822.52 Million ≈ $8.90 Million |
Rs144.72 Million ≈ $1.57 Million |
0.176x | +221.79% |
| 2025-03-31 | Rs774.04 Million ≈ $8.37 Million |
Rs42.32 Million ≈ $457.70K |
0.055x | -83.39% |
| 2024-03-31 | Rs692.61 Million ≈ $7.49 Million |
Rs228.06 Million ≈ $2.47 Million |
0.329x | +1237.80% |
| 2023-03-31 | Rs637.02 Million ≈ $6.89 Million |
Rs-18.43 Million ≈ $-199.37K |
-0.029x | -106.11% |
| 2022-03-31 | Rs584.92 Million ≈ $6.33 Million |
Rs277.08 Million ≈ $3.00 Million |
0.474x | +16.04% |
| 2021-03-31 | Rs533.54 Million ≈ $5.77 Million |
Rs217.81 Million ≈ $2.36 Million |
0.408x | -19.88% |
| 2020-03-31 | Rs453.38 Million ≈ $4.90 Million |
Rs231.01 Million ≈ $2.50 Million |
0.510x | +295.55% |
| 2019-03-31 | Rs602.21 Million ≈ $6.51 Million |
Rs77.58 Million ≈ $838.95K |
0.129x | +1663.52% |
| 2018-03-31 | Rs602.01 Million ≈ $6.51 Million |
Rs-4.96 Million ≈ $-53.64K |
-0.008x | -108.44% |
| 2017-03-31 | Rs600.31 Million ≈ $6.49 Million |
Rs58.58 Million ≈ $633.56K |
0.098x | +127.59% |
| 2016-03-31 | Rs547.22 Million ≈ $5.92 Million |
Rs-193.53 Million ≈ $-2.09 Million |
-0.354x | -234.25% |
| 2015-03-31 | Rs551.68 Million ≈ $5.97 Million |
Rs145.33 Million ≈ $1.57 Million |
0.263x | -0.97% |
| 2014-03-31 | Rs500.50 Million ≈ $5.41 Million |
Rs133.13 Million ≈ $1.44 Million |
0.266x | -27.36% |
| 2013-03-31 | Rs446.18 Million ≈ $4.83 Million |
Rs163.39 Million ≈ $1.77 Million |
0.366x | +14.07% |
| 2012-03-31 | Rs400.56 Million ≈ $4.33 Million |
Rs128.58 Million ≈ $1.39 Million |
0.321x | +151.97% |
| 2011-03-31 | Rs361.75 Million ≈ $3.91 Million |
Rs46.09 Million ≈ $498.42K |
0.127x | +187.92% |
| 2010-03-31 | Rs357.62 Million ≈ $3.87 Million |
Rs-51.82 Million ≈ $-560.40K |
-0.145x | -142.27% |
| 2009-03-31 | Rs372.35 Million ≈ $4.03 Million |
Rs127.64 Million ≈ $1.38 Million |
0.343x | +32.33% |
| 2008-03-31 | Rs350.32 Million ≈ $3.79 Million |
Rs90.75 Million ≈ $981.39K |
0.259x | +67.86% |
| 2007-03-31 | Rs334.02 Million ≈ $3.61 Million |
Rs51.55 Million ≈ $557.46K |
0.154x | +183.48% |
| 2006-03-31 | Rs323.02 Million ≈ $3.49 Million |
Rs-59.71 Million ≈ $-645.75K |
-0.185x | -- |
About Bal Pharma Limited
Bal Pharma Limited, together with its subsidiaries, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk drugs. It also provides anti-infectives, pain management, respiratory care, and women's health products under the Az… Read more